Latest Posts
-
CEO Espresso Interview: Rohit Jha
Question: Tell us briefly about Transcelestial and your role as CEO. Answer: Transcelestial is focused on space-based infrastructure — satellites, security, and how we protect data and systems in orbit. I founded the company after working in both government and academia, and we’re trying to bridge that gap: deep tech, but practical applications. Our mission
-
3 common mistakes in pharma market access negotiations – and how to avoid them
Market access is often the decisive bottleneck: without successful payer negotiations, even the most innovative product will fail commercially. From my experience, three mistakes repeat again and again: These mistakes cost time, credibility, and millions. With structured frameworks and early preparation, they can be avoided. What has been your experience in payer negotiations?
-
Asia-Pacific BioPharma Insights
Country Spotlight Series: Japan Biotech & Pharma Deep Dive Market Overview Japan is one of the most mature and innovation-driven biotech and pharmaceutical markets, valued at ~$45B in 2023 and projected to reach ~$80–100B by 2030. Key drivers include an aging population, strong R&D ecosystem, and pioneering regulatory frameworks. Innovation Highlights Major Players & Ecosystems